The PMD-200™ integrates the NOL® index to provide accurate, continuous and noninvasive nociception (pain response) monitoring for personalized analgesic treatment during surgery.
Intraoperative nociception and analgesia have traditionally been assessed indirectly through changes in heart rate / blood pressure – which are not sufficiently sensitive or specific.
Insufficient or excessive analgesia could lead to postoperative pain, complications, delayed recovery, and associated costs3, 4, 5.
of surgical patients suffer from moderate to severe post-operative pain.
Of surgical patients suffer from adverse events due to analgesic medications, leading to:
The PMD-200™ by Medasense is a non-invasive and continuous pain monitoring device.
By using the PMD-200™ in operating rooms, where patients under general anaesthesia are unable to communicate their pain, clinicians are able to assess nociception, and tailor analgesic medication to meet the patient’s sensitivity and specific needs.
Recognizing the complex nature of pain, the PMD-200’s integrated NOL® (Nociception Level) technology considers multiple nociception-related physiological parameters and its various derivatives. Advanced algorithms process the multiple data streams, identify pain-related patterns, and reflect the patient’s nociceptive state.
Clinical studies have shown that NOL-guided intraoperative analgesia can achieve: